[
  {
    "ts": null,
    "headline": "Globus Medical: Some Caution After Its Deal For Nevro",
    "summary": "Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read why I'm neutral on GMED stock.",
    "url": "https://finnhub.io/api/news?id=79420be33fb373da910abf2c3d62569d9a07e53ef6d40eb0c3cab997be21bdee",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739689537,
      "headline": "Globus Medical: Some Caution After Its Deal For Nevro",
      "id": 132739175,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/124205767/image_124205767.jpg?io=getty-c-w1536",
      "related": "SYK",
      "source": "SeekingAlpha",
      "summary": "Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read why I'm neutral on GMED stock.",
      "url": "https://finnhub.io/api/news?id=79420be33fb373da910abf2c3d62569d9a07e53ef6d40eb0c3cab997be21bdee"
    }
  }
]